Business Context and Reporting Period
This Form 8-K Current Report was filed by TriSalus Life Sciences, Inc. on February 25, 2025, covering an event dated February 19, 2025. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Westminster, Colorado.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
On February 19, 2025, Sean Murphy notified the Company of his intent to step down as an officer and employee, effective February 28, 2025. Mr. Murphy will continue to serve as a member of the Board of Directors.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the personnel change described in Item 5.02.
Investor Verification Checklist
- Confirm the exact effective date of Sean Murphy's departure as an officer (February 28, 2025).
- Verify that Mr. Murphy retains his seat on the Board of Directors.
- Check for any subsequent filings regarding the appointment of a replacement officer.